Cell-specific contrast agent and gene delivery vehicles

Jon Faiz Kayyem (Inventor), Thomas J Meade (Inventor), Scott E. Fraser (Inventor)

Research output: Patent

Abstract

A delivery vehicle is described that is capable of being specifically bound to and taken into targeted cells, delivering numerous paramagnetic ions for magnetic resonance imaging (MRI) of the cells. The delivery vehicle comprises a polymeric molecule having a net positive charge complexed with another polymeric molecule having a net negative charge. Cell targeting moieties and MRI contrast agents are attached to one or both of the polymeric molecules. In one embodiment, the polymeric molecule having a net negative charge is a nucleic acid. Thus, the delivery vehicles can be used in clinical protocols in which nucleic acids for gene therapy and agents for MRI contrast are co-transported to specific cells allowing medical imaging monitoring of nucleic acid delivery.
Original languageEnglish (US)
Patent number6232295
Filing date10/12/94
StatePublished - May 15 2001

Fingerprint Dive into the research topics of 'Cell-specific contrast agent and gene delivery vehicles'. Together they form a unique fingerprint.

Cite this